Carole D. Mitnick
8 ta ish
Harvard University
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja, David Ashkin, Monika Avendano +70
Sharh maqolaOchiq kirish20129 iqtibosABITreatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97
Sharh maqolaOchiq kirish20184 iqtibosABIPredictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
Ekaterina V. Kurbatova, A. Taylor, Victoria M. Gammino +13
MaqolaOchiq kirish20124 iqtibosABIPrinciples for designing future regimens for multidrug-resistant tuberculosis
Grania Brigden, Bern-Thomas Nyang’wa, Philipp du Cros +9
MaqolaOchiq kirish20133 iqtibosABICounting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis
Molly F. Franke, Mercedes C. Becerra, Dylan B. Tierney +5
MaqolaOchiq kirish20153 iqtibosABIWHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Dennis Falzon, E. Jaramillo, Holger J. Schünemann +43
MaqolaOchiq kirish20113 iqtibosABICharacteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis
Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97
Sharh maqolaOchiq kirishTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibosABI